Health Care research and M&A coverage
Sector outlooks and M&A updates for 36 industries: how the market prices them, which comparables set the range, and what has transacted.
For information only. Not an appraisal or a fairness opinion.
Industries in this sector
- Antibody and Protein Therapeutics
- Biotechnology
- Cardiovascular Devices
- Cell and Gene Therapies
- Clinical Laboratory Services
- Contract Development and Manufacturing (CDMO)
- Contract Research Organizations (CRO)
- Diagnostic and Testing Equipment
- Digital Health and Telehealth
- Generic and Non-Prescription Drugs
- Genetic and Screening Services
- Health Care Data and Analytics
- Health Care Distributors
- Health Care Equipment and Supplies
- Health Care Workforce Services
- Health Insurance and Benefits Management
- Home Health and Long-Term Care
- Hospitals and Health Systems
- Immunology and Inflammation Therapeutics
- Life Sciences Research Reagents and Supplies
- Life Sciences Tools and Instruments
- Managed Health Care
- Medical Devices
- Medical Imaging Equipment
- Neurology and CNS Therapeutics
- Oncology Therapeutics
- Ophthalmic Therapeutics
- Outpatient and Specialty Care Services
- Pharmaceuticals
- Rare and Orphan Disease Therapeutics
- Regenerative Medicine
- Specialty and Branded Pharmaceuticals
- Surgical and Orthopedic Devices
- Therapeutic and Monitoring Devices
- Therapeutic Discovery Platforms
- Vaccines
Reports by industry
Antibody and Protein Therapeutics
- Antibody and Protein Therapeutics Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Antibody and Protein Therapeutics M&A update, 14–28 September 2026M&A Update · 29 September 2026
Biotechnology
- Biotechnology Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Biotechnology M&A update, 14–28 September 2026M&A Update · 29 September 2026
Cardiovascular Devices
- Cardiovascular Devices Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Cardiovascular Devices M&A update, 14–28 September 2026M&A Update · 29 September 2026
Cell and Gene Therapies
- Cell and Gene Therapies Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Cell and Gene Therapies M&A update, 14–28 September 2026M&A Update · 29 September 2026
Clinical Laboratory Services
- Clinical Laboratory Services Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Clinical Laboratory Services M&A update, 14–28 September 2026M&A Update · 29 September 2026
Contract Development and Manufacturing (CDMO)
- Contract Development and Manufacturing (CDMO) Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Contract Development and Manufacturing (CDMO) M&A update, 14–28 September 2026M&A Update · 29 September 2026
Contract Research Organizations (CRO)
- Contract Research Organizations (CRO) Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Contract Research Organizations (CRO) M&A update, 14–28 September 2026M&A Update · 29 September 2026
Diagnostic and Testing Equipment
- Diagnostic and Testing Equipment Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Diagnostic and Testing Equipment M&A update, 14–28 September 2026M&A Update · 29 September 2026
Digital Health and Telehealth
- Digital Health and Telehealth Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Digital Health and Telehealth M&A update, 14–28 September 2026M&A Update · 29 September 2026
Generic and Non-Prescription Drugs
- Generic and Non-Prescription Drugs Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Generic and Non-Prescription Drugs M&A update, 14–28 September 2026M&A Update · 29 September 2026
Genetic and Screening Services
- Genetic and Screening Services Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Genetic and Screening Services M&A update, 14–28 September 2026M&A Update · 29 September 2026
Health Care Data and Analytics
- Health Care Data and Analytics Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Health Care Data and Analytics M&A update, 14–28 September 2026M&A Update · 29 September 2026
Health Care Distributors
- Health Care Distributors Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Health Care Distributors M&A update, 14–28 September 2026M&A Update · 29 September 2026
Health Care Equipment and Supplies
- Health Care Equipment and Supplies Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Health Care Equipment and Supplies M&A update, 14–28 September 2026M&A Update · 29 September 2026
Health Care Workforce Services
- Health Care Workforce Services Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Health Care Workforce Services M&A update, 14–28 September 2026M&A Update · 29 September 2026
Health Insurance and Benefits Management
- Health Insurance and Benefits Management Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Health Insurance and Benefits Management M&A update, 14–28 September 2026M&A Update · 29 September 2026
Home Health and Long-Term Care
- Home Health and Long-Term Care Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Home Health and Long-Term Care M&A update, 14–28 September 2026M&A Update · 29 September 2026
Hospitals and Health Systems
- Hospitals and Health Systems Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Hospitals and Health Systems M&A update, 14–28 September 2026M&A Update · 29 September 2026
Immunology and Inflammation Therapeutics
- Immunology and Inflammation Therapeutics Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Immunology and Inflammation Therapeutics M&A update, 14–28 September 2026M&A Update · 29 September 2026
Life Sciences Research Reagents and Supplies
- Life Sciences Research Reagents and Supplies Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Life Sciences Research Reagents and Supplies M&A update, 14–28 September 2026M&A Update · 29 September 2026
Life Sciences Tools and Instruments
- Life Sciences Tools and Instruments Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Life Sciences Tools and Instruments M&A update, 14–28 September 2026M&A Update · 29 September 2026
Managed Health Care
- Managed Health Care Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Managed Health Care M&A update, 14–28 September 2026M&A Update · 29 September 2026
Medical Devices
- Medical Devices Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Medical Devices M&A update, 14–28 September 2026M&A Update · 29 September 2026
Medical Imaging Equipment
- Medical Imaging Equipment Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Medical Imaging Equipment M&A update, 14–28 September 2026M&A Update · 29 September 2026
Neurology and CNS Therapeutics
- Neurology and CNS Therapeutics Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Neurology and CNS Therapeutics M&A update, 14–28 September 2026M&A Update · 29 September 2026
Oncology Therapeutics
- Oncology Therapeutics Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Oncology Therapeutics M&A update, 14–28 September 2026M&A Update · 29 September 2026
Ophthalmic Therapeutics
- Ophthalmic Therapeutics Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Ophthalmic Therapeutics M&A update, 14–28 September 2026M&A Update · 29 September 2026
Outpatient and Specialty Care Services
- Outpatient and Specialty Care Services Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Outpatient and Specialty Care Services M&A update, 14–28 September 2026M&A Update · 29 September 2026
Pharmaceuticals
- Pharmaceuticals Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Pharmaceuticals M&A update, 14–28 September 2026M&A Update · 29 September 2026
Rare and Orphan Disease Therapeutics
- Rare and Orphan Disease Therapeutics Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Rare and Orphan Disease Therapeutics M&A update, 14–28 September 2026M&A Update · 29 September 2026
Regenerative Medicine
- Regenerative Medicine Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Regenerative Medicine M&A update, 14–28 September 2026M&A Update · 29 September 2026
Specialty and Branded Pharmaceuticals
- Specialty and Branded Pharmaceuticals Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Specialty and Branded Pharmaceuticals M&A update, 14–28 September 2026M&A Update · 29 September 2026
Surgical and Orthopedic Devices
- Surgical and Orthopedic Devices Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Surgical and Orthopedic Devices M&A update, 14–28 September 2026M&A Update · 29 September 2026
Therapeutic and Monitoring Devices
- Therapeutic and Monitoring Devices Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Therapeutic and Monitoring Devices M&A update, 14–28 September 2026M&A Update · 29 September 2026
Therapeutic Discovery Platforms
- Therapeutic Discovery Platforms Sector Outlook — September 2026Sector Outlook · 29 September 2026
- Therapeutic Discovery Platforms M&A update, 14–28 September 2026M&A Update · 29 September 2026
Vaccines
- Vaccines Sector Outlook — September 2026Sector Outlook · 29 September 2026
Company valuation reports are listed on the company reports page.
Need coverage on a company in Health Care?
Company valuation reports run the same method against a single business, public or private.